Log in to your Inderes Free account to see all free content on this page.
Immunovia
0.22 SEK
-1.58 %
Less than 1K followers
IMMNOV
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Immunovia
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.2 | 0.4 | 0.9 | 0.1 | 0.1 | 0.1 | 0.4 | 0.7 |
| EBITDA | -23.7 | -28.8 | -96.0 | -18.0 | -19.7 | -24.6 | -15.7 | -78.1 |
| EBIT | -31.2 | -30.1 | -109.4 | -18.9 | -20.1 | -25.1 | -16.4 | -80.4 |
| EBIT-% | -13,012.5 % | -6,843.2 % | -11,764.5 % | -13,507.1 % | -22,277.8 % | -25,050.0 % | -4,550.0 % | -11,650.7 % |
| Profit before taxes | -51.1 | 3.1 | -76.5 | -57.8 | -41.1 | -29.7 | -17.3 | -145.9 |
| Net income | -51.1 | 3.1 | -76.5 | -57.8 | -41.1 | -29.7 | -17.3 | -145.9 |
Login required
This content is only available for logged in users